196 related articles for article (PubMed ID: 7577723)
1. Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells.
Botella J; Duranti E; Viader V; Duc I; Delansorne R; Paris J
J Steroid Biochem Mol Biol; 1995 Oct; 55(1):77-84. PubMed ID: 7577723
[TBL] [Abstract][Full Text] [Related]
2. An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells.
Shields-Botella J; Duc I; Duranti E; Puccio F; Bonnet P; Delansorne R; Paris J
J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):111-22. PubMed ID: 14672731
[TBL] [Abstract][Full Text] [Related]
3. Estrogenic and progestagenic activities coexisting in steroidal drugs: quantitative evaluation by in vitro bioassays with human cells.
Markiewicz L; Gurpide E
J Steroid Biochem Mol Biol; 1994 Jan; 48(1):89-94. PubMed ID: 8136310
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic estrogenicity of some progestagenic drugs.
Markiewicz L; Hochberg RB; Gurpide E
J Steroid Biochem Mol Biol; 1992 Jan; 41(1):53-8. PubMed ID: 1734936
[TBL] [Abstract][Full Text] [Related]
5. Modulation of aromatase activity in human endometrial stromal cells by steroids, tamoxifen and RU 486.
Tseng L; Mazella J; Sun B
Endocrinology; 1986 Apr; 118(4):1312-8. PubMed ID: 2936597
[TBL] [Abstract][Full Text] [Related]
6. [Actions of a 19-norprogesterone derivative on mammary gland: nomegestrol acetate].
André G
J Gynecol Obstet Biol Reprod (Paris); 2005 Feb; 34(1 Pt 1):69-84. PubMed ID: 15767920
[TBL] [Abstract][Full Text] [Related]
7. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines.
Schoonen WG; Joosten JW; Kloosterboer HJ
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):423-37. PubMed ID: 8541240
[TBL] [Abstract][Full Text] [Related]
8. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
Jeng MH; Parker CJ; Jordan VC
Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300
[TBL] [Abstract][Full Text] [Related]
9. Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions.
Houshdaran S; Chen JC; Vallvé-Juanico J; Balayan S; Vo KC; Smith-McCune K; Greenblatt RM; Irwin JC; Giudice LC
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283828
[TBL] [Abstract][Full Text] [Related]
10. New progestagens for contraceptive use.
Sitruk-Ware R
Hum Reprod Update; 2006; 12(2):169-78. PubMed ID: 16291771
[TBL] [Abstract][Full Text] [Related]
11. Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays.
Markiewicz L; Gurpide E
Methods Find Exp Clin Pharmacol; 1997 May; 19(4):215-22. PubMed ID: 9228646
[TBL] [Abstract][Full Text] [Related]
12. Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids.
Poulin R; Baker D; Poirier D; Labrie F
Breast Cancer Res Treat; 1991; 17(3):197-210. PubMed ID: 1645605
[TBL] [Abstract][Full Text] [Related]
13. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
14. Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity.
Catherino WH; Jordan VC
J Steroid Biochem Mol Biol; 1995 Nov; 55(2):239-46. PubMed ID: 7495704
[TBL] [Abstract][Full Text] [Related]
15. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Hyder SM; Murthy L; Stancel GM
Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
[TBL] [Abstract][Full Text] [Related]
16. The estrogenic activity of synthetic progestins used in oral contraceptives.
Jordan VC; Jeng MH; Catherino WH; Parker CJ
Cancer; 1993 Feb; 71(4 Suppl):1501-5. PubMed ID: 8431886
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and progestin regulation of the progesterone receptor concentration in human endometrium.
Kreitmann B; Bugat R; Bayard F
J Clin Endocrinol Metab; 1979 Dec; 49(6):926-9. PubMed ID: 92478
[TBL] [Abstract][Full Text] [Related]
18. Endocrine aspects of human uterine sarcoma: a preliminary study.
Tseng L; Tseng JK; Mann WJ; Chumas JC; Stone ML; Mazella J; Sun B; Amalfitano TG; Wallach RC
Am J Obstet Gynecol; 1986 Jul; 155(1):95-101. PubMed ID: 2942037
[TBL] [Abstract][Full Text] [Related]
19. Nestorone: a progestin with a unique pharmacological profile.
Kumar N; Koide SS; Tsong Y; Sundaram K
Steroids; 2000; 65(10-11):629-36. PubMed ID: 11108869
[TBL] [Abstract][Full Text] [Related]
20. Changes in the transcriptome of the human endometrial Ishikawa cancer cell line induced by estrogen, progesterone, tamoxifen, and mifepristone (RU486) as detected by RNA-sequencing.
Tamm-Rosenstein K; Simm J; Suhorutshenko M; Salumets A; Metsis M
PLoS One; 2013; 8(7):e68907. PubMed ID: 23874806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
